RDY | Dr. Reddy's LaboratoriesNYSEADR golden cross and death cross projections, cross tests and history

$14.13
-$0.04 (-0.28%)

Dr. Reddy's Laboratories (RDY) is a NYSE-listed ADR that Cruxta has tracked for 50/200 crosses since 2018.

Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Nov 2025, but the two have been closing on each other and a golden cross is projected within 20 bars. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
above both $14.17 vs 50 $13.35 / 200 $13.72
Projection
Golden cross estimated 15+ weeks out
Test
No active test
Last cross
Death cross week of 24 Aug 2026 ยท projected 10 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $14.30 vs 50 $13.11 / 200 $12.77
Projection
No cross projected
Test
No active test
Last cross
Golden cross 27 Oct 2026 ยท projected 27 bars out

Cross history

30
crosses on record since 2018
15 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
27 Oct 2026Golden4-hour27 bars outNot tested
week of 24 Aug 2026Death flatweekly10 bars outNot tested
27 Jul 2026Death4-hour28 bars outNot tested
6 Jul 2026Golden4-hour22 bars out3 bar cross test
7 Apr 2026Death4-hour17 bars outNot tested

About RDY

ExchangeNYSE
InstrumentADR
Median $ volume, 60 d$34.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.